Valuation: RAMM Pharma Corp.

Market Cap 1.19M 850K 739K 690K 633K 81.02M 1.21M 8.13M 3.19M 40.4M 3.19M 3.12M 133M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 335K 291K 272K 249K 31.92M 479K 3.2M 1.25M 15.92M 1.26M 1.23M 52.51M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 850K
-2.39%-6.36%+47.10%+149.66% 1T
-0.76%-4.34%+52.04%+49.09% 613B
-2.33%-4.60%+25.55%+64.44% 433B
+0.88%-2.15%+41.18%+35.82% 350B
+0.60%-3.80%+32.63%+40.83% 292B
+2.03%-9.27%+5.42%+7.61% 239B
+2.22%-7.75%-1.15%-41.71% 206B
-1.63%+0.69%+27.62%+64.23% 204B
+0.72%+0.48%+15.88%+73.64% 163B
Average -7.22%-3.88%+27.36%+49.29% 388.94B
Weighted average by Cap. +0.40%-4.34%+35.22%+71.55%

Financials

2024 2025
Net sales 4.34M 3.09M 2.69M 2.51M 2.3M 295M 4.42M 29.58M 11.58M 147M 11.61M 11.35M 485M 3.36M 2.39M 2.08M 1.94M 1.78M 228M 3.42M 22.89M 8.97M 114M 8.99M 8.79M 375M
Net income -16.5M -11.75M -10.21M -9.53M -8.75M -1.12B -16.79M -112M -44.03M -558M -44.13M -43.16M -1.84B -8.91M -6.34M -5.51M -5.15M -4.73M -605M -9.07M -60.69M -23.77M -302M -23.83M -23.3M -995M
Net Debt -626K -446K -387K -361K -332K -42.46M -637K -4.26M -1.67M -21.18M -1.67M -1.64M -69.85M -723K -515K -448K -418K -384K -49.1M -736K -4.93M -1.93M -24.48M -1.93M -1.89M -80.76M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-